Schizophrenia is a devastating neurodevelopmental disorder that affects approximately 1% of the population. Reduced expression of the 67-kDa protein isoform of glutamic acid decarboxylase (GAD67) is a hallmark of the disease and is encoded by the GAD1 gene. In schizophrenia, GAD67 downregulation occurs in multiple interneuronal subpopulations, including the cannabinoid receptor type 1 positive (CNR1 +) cells, but the functional consequences of these disturbances are not well understood. To investigate the role of the CNR1-positive GABAergic interneurons in behavioral and molecular processes, we employed a novel, miRNA-mediated transgenic mouse approach. We silenced the Gad1 transcript using a miRNA engineered to specifically target Gad1 mRNA under the control of Cnr1 bacterial artificial chromosome. Behavioral characterization of our transgenic mice showed elevated and persistent conditioned fear associated with an auditory cue and a significantly altered response to an amphetamine challenge. These deficits could not be attributed to sensory deficits or changes in baseline learning and memory. Furthermore, HPLC analyses revealed that Cnr1/Gad1 mice have enhanced serotonin levels, but not dopamine levels in response to amphetamine. Our findings demonstrate that dysfunction of a small subset of interneurons can have a profound effect on behavior and that the GABA-ergic, monoamine, and cannabinoid systems are functionally interconnected. The results also suggest that understanding the function of various interneuronal subclasses might be essential to develop knowledge-based treatment strategies for various mental disorders including schizophrenia and substance abuse.
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Introduction
Genetic and pharmacological studies have demonstrated that endocannabinoids (eCBs) and drugs targeting the eCB system can affect neuronal development and differentiation (Galve-Roperh et al., 2008; Harkany et al., 2007) . Several recent epidemiological studies have associated increased psychotic episodes and a higher probability to develop schizophrenia as a result of adolescent cannabis abuse (Henquet et al., 2005; Matheson et al., 2011; Muller-Vahl and Emrich, 2008; van Os et al., 2002; Veen et al., 2004) Furthermore, cannabis abuse can also induce acute psychosis (Morrison et al., 2009 ).
The eCB system regulates emotion, stress, memory and cognition. The eCB N-arachidonylethanolamine (AEA) and 2-arachidonoylglycerol (2-AG) are synthesized and released postsynaptically to act as retrograde messengers at presynaptic cannabinoid receptor 1 (CNR1, also known as CB1R or CB1A) located on both glutamatergic and gammaaminobutyric acid (GABA)-ergic axon terminals (Katona et al., 2001 (Katona et al., , 2006 . They suppress neurotransmitter release (Wilson et al., 2001) and are very effective modulators of synaptic plasticity (Katona and Freund, 2012) . In the adult brain, CNR1 is expressed at high levels in the neocortex, hippocampus, striatum, amygdala and cerebellum (Pettit et al., 1998; Tsou et al., 1998) . On GABAergic interneurons, CNR1 is primarily expressed on basket cells and represents a smaller subpopulation of cholecystokinin (CCK) expressing interneurons (Eggan et al., 2010a; Katona et al., 2000 Katona et al., , 2001 . They are slowly adapting and are coupled to 3-8 Hz theta oscillations (Klausberger and Somogyi, 2008) .
Previous animal studies have focused on genetic inactivation of Cnr1 receptors. These animals showed increased mortality, hypoactivity, hypoalgesia (Zimmer et al., 1999) , as well as elevated arousal/anxiety that might promote enhanced social discrimination memory (Litvin et al., 2013; Martin et al., 2002) . However, the majority of these Neurobiology of Disease 63 (2014) 210-221 
